ACR Appropriateness Criteria Myelopathy
Christopher J. Roth(Duke Medical Center), Julie Bykowski(University of California San Diego), Langston T. Holly(University of California, Los Angeles), Vilaas Shetty(Saint Louis University Hospital), Claudia Kirsch(The Ohio State University Wexner Medical Center), Marcus M. Kessler(University of Arkansas for Medical Sciences), Michael D. Luttrull(The Ohio State University Wexner Medical Center), Asim F. Choudhri(Le Bonheur Children's Hospital), Laszlo Mechtler(American Academy of Neurology), Aseem Sharma(Mallinckrodt (United States)), Peter D. Angevine(Columbia University Irving Medical Center), Ian Blair Fries(American Academy of Orthopaedic Surgeons), A. Tuba Kendi(Emory University Hospital), John E. OʼToole(American Association of Neurological Surgeons), O. Clark West(The University of Texas Health Science Center at Houston), Rebecca S. Cornelius(University of Cincinnati), Kevin L. Berger, Joseph M. Aulino(Vanderbilt University)
Cited by 25
Related Papers
Clinical Practice Guideline: Ménière’s Disease
|Otolaryngology|2020|301
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
|The Lancet Oncology|2021|257
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study
|Journal of Clinical Oncology|2020|119
ACR Appropriateness Criteria Head Trauma
|Journal of the American College of Radiology|2016|117
ACR Appropriateness Criteria ® Sinonasal Disease
|Journal of the American College of Radiology|2017|95